Hangzhou Zheda Dixun Biogenetic Engineering Co., Ltd.

Release date：2018-11-13

JACI

[IF:13.1]

Advances in mechanisms of allergic disease in 2017
DOI: 10.1016/j.jaci.2018.09.027
Abstract:
This review highlights advances in mechanisms of allergic disease, particularly type 2 innate lymphoid cells, TH2 lymphocytes, B cells, dendritic cells, microbiome and barrier function, eosinophils, and mast cells. During the last year, considerable progress has been made in the further characterization of type 2 inflammation controlled by both adaptive (TH2) and type 2 innate lymphoid effector cells. New pathways of lymphocyte activation, trafficking, and recruitment and effector cell mechanisms have been discovered. The plasticity of lymphocyte effector cell responses is another area in which major progress has been achieved. Accumulating evidence will influence both our understanding of allergic disease and our efforts for allergy prevention and treatment.
All Authors:
ChrysanthiSkevakiMD, PhDabHaraldRenzMDa

2018-10-24 Review

Hangzhou Zheda Dixun Biological Gene Engineering Co., Ltd. Copyright HZKC Technical support 浙ICP备14005341号（浙）-非经营性-2019-0050

Address: Rm.201-209, Bldg.2, No.568 Binkang Rd., Binjiang Dist. Tel: 0571-87968248-805 Website:www.zdbiogene.com

Official WeChat

杭州浙大迪迅生物基因工程有限公司

Release date：2018-11-13